LAUSR

OBJECTIVES Examining the associations of COVID-19 related anxiety and insomnia with increased smoking following the outbreak of the COVID-19 pandemic, and investigating whether increased insomnia severity mediates the association between COVID-19 related anxiety and increased smoking. METHODS 598 participants, aged 18-40, out of whom 140 self-identified as smokers, completed online questionnaires during the third wave of the COVID-19 pandemic. Measures included two items assessing COVID-19 related anxiety, the Pittsburgh Sleep Quality Index, and the Insomnia Severity Index, which included a pre-pandemic retrospective report. RESULTS Compared with nonsmokers, smokers reported lower sleep quality and more severe symptoms of insomnia. Among smokers, more severe symptoms of insomnia were associated with greater odds of increased smoking during the COVID-19 outbreak. COVID-19 related anxiety was indirectly associated with greater odds of increased smoking through greater insomnia severity during the COVID-19 outbreak, after controlling for pre-pandemic levels of insomnia. CONCLUSIONS Smokers experienced more sleep difficulties during the COVID-19 pandemic than nonsmokers. The results also lend support to the suggestion that anxiety, such that was experienced during the COVID-19 pandemic, may lead to further exacerbation of sleep difficulties, leading in turn to increase in smoking. These findings have important clinical implications that may be particularly relevant to attempts to minimize smoking during stressful circumstances.